POSC Stock Overview
Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Positron Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.15 |
| 52 Week High | US$1.97 |
| 52 Week Low | US$0.87 |
| Beta | 0 |
| 1 Month Change | -8.47% |
| 3 Month Change | -8.00% |
| 1 Year Change | -19.58% |
| 3 Year Change | 64.29% |
| 5 Year Change | 858.33% |
| Change since IPO | -99.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| POSC | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 4.5% | 1.4% | 1.2% |
| 1Y | -19.6% | -0.7% | 24.7% |
Return vs Industry: POSC underperformed the US Medical Equipment industry which returned -0.7% over the past year.
Return vs Market: POSC underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| POSC volatility | |
|---|---|
| POSC Average Weekly Movement | 14.3% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: POSC's share price has been volatile over the past 3 months.
Volatility Over Time: POSC's weekly volatility has decreased from 20% to 14% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | n/a | n/a | www.positron.com |
Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.
Positron Corporation Fundamentals Summary
| POSC fundamental statistics | |
|---|---|
| Market cap | US$29.82m |
| Earnings (TTM) | -US$1.27m |
| Revenue (TTM) | US$1.24m |
0.0x
P/S Ratio0.0x
P/E RatioIs POSC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| POSC income statement (TTM) | |
|---|---|
| Revenue | US$1.24m |
| Cost of Revenue | US$829.00k |
| Gross Profit | US$408.00k |
| Other Expenses | US$1.68m |
| Earnings | -US$1.27m |
Last Reported Earnings
Sep 30, 2015
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did POSC perform over the long term?
See historical performance and comparison